A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
About Beckman Research Institute Bookmark and Share

Beckman Research Institute of City of Hope

Nestled in the foothills of the San Gabriel Mountains, Beckman Research Institute was the first of five Beckman Institutes to be founded. The Beckman Institute at City of Hope is unique because it has held a National Cancer Institute Cancer Center Support Grant for more than 30 years.
 
It encompasses over 60 years of expertise in basic science that includes research at City of Hope prior to the establishment of the Institute by Arnold and Mabel Beckman in 1983. Faculty and investigators here revolutionize the treatment of life-threatening diseases. They are focused on investigating the biology, biological chemistry, and pathology of cancer and diabetes, and they examine the emerging links between the two. Researchers are committed to identifying opportunities at the cellular and molecular level to predict, prevent, diagnose, treat and cure these and other serious diseases.
 
Fundamental advances in understanding of acute illnesses translate into an improved armamentarium for clinicians at City of Hope, which for 10 years has been ranked a U.S.News & World Report Best Cancer Hospital.

Beckman Research Institute investigators examine a wide range of research areas that includes diabetes progression and treatment, immunology and imaging, interfering RNAs and HIV treatment, total synthesis of complex and therapeutic natural products, mechanisms of drug action, neurogenesis, DNA repair and radiation, and the immunobiology of viral infection.
 
In addition, the City of Hope NCI-Designated Comprehensive Cancer Center is comprised of five research programs in the areas of basic, translational, and prevention research: Cancer Biology, Developmental Cancer Therapeutics, Cancer Immunotherapeutics, Hematologic Malignancies, and Cancer Control & Population Sciences. These programs conduct activities across the entire Duarte campus facilitating interactions among researchers and clinicians of all disciplines.
 
 
 

Scientific Leadership and Administration

Beckman Research Institute Departments and Divisions

The Department of Cancer Biology offers a multidisciplinary research and training environment in molecular biology, genetics, epigenetics and developmental biology.
 
Dedicated to discovering immune-based cancer therapies, the Department of Cancer Immunotherapeutics & Tumor Immunology conducts research in a new and evolving field and is known particularly for its studies using genetically engineered T-cells.
 
This department focuses on understanding the genetic and molecular bases of diabetes, developing novel treatment approaches for diabetes and preventing associated diseases such as cancer, heart disease and stroke.
 
 
The Department of Experimental Therapeutics develops vaccines to combat hematologic malignancies, solid tumors, and infectious pathogens such as CMV and HIV.
 
Gene Therapy
 
A pioneer in bone marrow transplantation, this department is part of one of the largest, most successful bone marrow and stem cell transplantation programs of its kind in the world and continues to refine the science of transplantation. The focus is to improve the understanding of leukemia stem cells in order to develop cures for leukemia and other hematologic malignancies
 
With a dual focus on immunology and structural biology, the Department of Immunology explores cancer immunology and biochemistry, antigen processing and T cell development.
 
The Department of Information Sciences (DIS) consisting of the Divisions of Biostatistics, Mathematical Oncology, Research Informatics and Clinical Research Information Support, collaborates in numerous facets of both clinical and basic science research throughout the Cancer Center and Beckman Research Institute, including study design, data quality and training and computational statistical analysis.
Maintaining a strong emphasis on the interface of chemistry and biology, the Department of Molecular and Cellular Biology focuses on gene structure, modeling of antibodies, theoretical biology and more.
Established in 1996, the Department of Molecular Medicine seeks to understand basic mechanisms underlying cancer and other diseases for the purpose of developing novel molecular therapeutics.
The Department of Neurosciences focuses on a range of research related to the brain and nervous system, including studies of molecular neurobiology/neurochemistry, neurophysiology, neuromorphology and molecular genetics.
 
Department researchers collaborate to better understand the causes of cancer, improve outcomes and develop ways to prevent cancer through discoveries made in population studies, survivorship, patterns of care and more.
 
  • Division of Cancer Etiology
    The goal of the Division of Cancer Etiology is to understand the causes of cancer. By understanding the causes of cancer, solutions can be developed to help prevent cancer, especially in people who are at highest risk.
     
  • Division of Clinical Cancer Genetics
    The Division of Clinical Cancer Genetics includes clinical services, research, and educational programs focusing on people who are at increased risk for developing cancer because of family history or personal risk factors.
     
  • Division of Outcomes Research
    The goal of the Division of Outcomes Research is to better understand the after-effects (physical, emotional, and social) of cancer and its treatment.
    • Center for Cancer Survivorship
      This is a clinical long-term follow-up program designed to create a bridge between cancer treatment and community medical care.
       
  • Division of Nursing Research and Education
    The Division of Nursing Research and Education is well recognized on a national level for its research and education focused on nursing care for patients with cancer, which has helped to increase the quality of care provided to cancer patients across the United States.
     
  • Center of Community Alliance for Research and Education (CCARE)
    CCARE is a broad initiative that facilitates the translation of scientific knowledge into community practice to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing to underrepresented and underserved patients and communities the best that City of Hope has to offer.
The Department of Radiation Biology studies the fundamental mechanisms of cancers and radiation resistance in cancer cells to find a solution to improve the efficacy of radiation therapy.

 
 

Research Department Chairs

Research Division Directors

Beckman Research Institute Milestones

2001
The Graduate School of Biological Sciences is accredited.

Fouad Kandeel, M.D., Ph.D., wins NIH approval for City of Hope as one of 10 national centers for isolating and distributing islet cells for transplantation into patients with Type 1 diabetes.


2005
The Division of Cancer Immunotherapeutics and Tumor Immunology is created.


2006
Arthur Riggs, Ph.D., is elected to the National Academy of Sciences in recognition of his work explaining how methylation modifies and changes the function of DNA.


2007
Groundbreaking on the Arnold and Mabel Beckman Center for Cancer Immunotherapeutics and Tumor Immunology.


2008
John Rossi, Ph.D., and John Zaia, M.D., open the first-in-human clinical trial for HIV related malignancies using a lentiviral vector to deliver a triple small RNA based gene therapy.

Richard Jove, Ph.D., is named director of the Beckman Research Institute.

Arthur Riggs, Ph.D., receives California Institute of Technology Distinguished Alumni Award.

The Department of Diabetes and Metabolic Diseases is created.
 

Beckman Research Institute Milestones

1984
The Beckman Research Institute is dedicated.

Arthur Riggs, Ph.D., and Shmuel Cabilly, Ph.D., demonstrate the feasibility and describe a method for making humanized monoclonal antibodies, technology later used in “smart” cancer drugs such as Herceptin, Rituxan and Avastin.


1988
Eugene Roberts, Ph.D., is elected to the National Academy of Sciences in recognition of his work on the existence and function of GABA and other neurotransmitters on the brain and nervous system.


1990
John Rossi, Ph.D., reports first use of RNA to block the progress of the virus that causes AIDS.


1994
The Graduate School of Biological Sciences is chartered.


1996
The Division of Molecular Medicine is created.

Gerd Pfeifer, Ph.D., definitively links smoking to lung cancer, identifying the genetic damage done by the active compounds in cigarettes.


1998
The Division of Molecular Biology is created.

Barry Forman, M.D., Ph.D., identifies the first new steroid-like hormone in 30 years, androstanol, a hormone that reverses or halts gene activity.


1999
The Division of Virology is created.

Arthur Riggs, Ph.D., is named Director of the Beckman Research Institute.


2000
The Center for Biomedicine & Genetics is established to ensure that City of Hope scientific discoveries are efficiently translated from the research lab to the clinical setting.

Beckman Research Institute Milestones

These milestones outline how Beckman Research Institute of City of Hope has grown to become one of the nation’s premier centers for innovative biomedical research, advancing the fundamental understanding of molecular genetics, cellular biology and more.
 
1952
The Research Institute is dedicated
 
1960s
The Division of Neurosciences is created.

The Division of Biology is created.


1972
The Division of Immunology is created.


1976
The Bone Marrow Transplantation Program is initiated, making City of Hope one of the first of six medical centers in the nation to perform this lifesaving procedure.

Ernest Beutler, M.D., is elected to the National Academy of Sciences in recognition of his research on the genetics of hematological diseases.


1978
Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., synthesize the human insulin gene resulting in the production of Humulin®, a pure source of human insulin available to people with diabetes.


1979
Keiichi Itakura, Ph.D., and Arthur Riggs, Ph.D., pioneer the recombinant DNA techniques used to synthesize human growth hormone, enabling thousands of undersized youngsters to reach near-normal height.


1981
The National Cancer Institute awards the first in a series of major grants to City of Hope’s Bone Marrow Transplantation Program.

Susumu Ohno, D.V.M., Ph.D., is elected to the National Academy of Sciences in recognition of his work on X chromosome inactivation and his theory of evolution by gene duplication.


1982
Yoko Fujita-Yamaguchi, Ph.D., purifies the insulin receptor molecule.


1983
The Arnold and Mabel Beckman Foundation provides a $10 million grant to establish the Beckman Research Institute of City of Hope.

Rachmiel Levine, M.D., is elected to the National Academy of Sciences in recognition of his pioneering work on discovering how insulin controls blood sugar levels.
 

About Beckman Research Institute

Beckman Research Institute of City of Hope

Nestled in the foothills of the San Gabriel Mountains, Beckman Research Institute was the first of five Beckman Institutes to be founded. The Beckman Institute at City of Hope is unique because it has held a National Cancer Institute Cancer Center Support Grant for more than 30 years.
 
It encompasses over 60 years of expertise in basic science that includes research at City of Hope prior to the establishment of the Institute by Arnold and Mabel Beckman in 1983. Faculty and investigators here revolutionize the treatment of life-threatening diseases. They are focused on investigating the biology, biological chemistry, and pathology of cancer and diabetes, and they examine the emerging links between the two. Researchers are committed to identifying opportunities at the cellular and molecular level to predict, prevent, diagnose, treat and cure these and other serious diseases.
 
Fundamental advances in understanding of acute illnesses translate into an improved armamentarium for clinicians at City of Hope, which for 10 years has been ranked a U.S.News & World Report Best Cancer Hospital.

Beckman Research Institute investigators examine a wide range of research areas that includes diabetes progression and treatment, immunology and imaging, interfering RNAs and HIV treatment, total synthesis of complex and therapeutic natural products, mechanisms of drug action, neurogenesis, DNA repair and radiation, and the immunobiology of viral infection.
 
In addition, the City of Hope NCI-Designated Comprehensive Cancer Center is comprised of five research programs in the areas of basic, translational, and prevention research: Cancer Biology, Developmental Cancer Therapeutics, Cancer Immunotherapeutics, Hematologic Malignancies, and Cancer Control & Population Sciences. These programs conduct activities across the entire Duarte campus facilitating interactions among researchers and clinicians of all disciplines.
 
 
 

Scientific Leadership and Administration

Scientific Leadership and Administration

Departments and Divisions

Beckman Research Institute Departments and Divisions

The Department of Cancer Biology offers a multidisciplinary research and training environment in molecular biology, genetics, epigenetics and developmental biology.
 
Dedicated to discovering immune-based cancer therapies, the Department of Cancer Immunotherapeutics & Tumor Immunology conducts research in a new and evolving field and is known particularly for its studies using genetically engineered T-cells.
 
This department focuses on understanding the genetic and molecular bases of diabetes, developing novel treatment approaches for diabetes and preventing associated diseases such as cancer, heart disease and stroke.
 
 
The Department of Experimental Therapeutics develops vaccines to combat hematologic malignancies, solid tumors, and infectious pathogens such as CMV and HIV.
 
Gene Therapy
 
A pioneer in bone marrow transplantation, this department is part of one of the largest, most successful bone marrow and stem cell transplantation programs of its kind in the world and continues to refine the science of transplantation. The focus is to improve the understanding of leukemia stem cells in order to develop cures for leukemia and other hematologic malignancies
 
With a dual focus on immunology and structural biology, the Department of Immunology explores cancer immunology and biochemistry, antigen processing and T cell development.
 
The Department of Information Sciences (DIS) consisting of the Divisions of Biostatistics, Mathematical Oncology, Research Informatics and Clinical Research Information Support, collaborates in numerous facets of both clinical and basic science research throughout the Cancer Center and Beckman Research Institute, including study design, data quality and training and computational statistical analysis.
Maintaining a strong emphasis on the interface of chemistry and biology, the Department of Molecular and Cellular Biology focuses on gene structure, modeling of antibodies, theoretical biology and more.
Established in 1996, the Department of Molecular Medicine seeks to understand basic mechanisms underlying cancer and other diseases for the purpose of developing novel molecular therapeutics.
The Department of Neurosciences focuses on a range of research related to the brain and nervous system, including studies of molecular neurobiology/neurochemistry, neurophysiology, neuromorphology and molecular genetics.
 
Department researchers collaborate to better understand the causes of cancer, improve outcomes and develop ways to prevent cancer through discoveries made in population studies, survivorship, patterns of care and more.
 
  • Division of Cancer Etiology
    The goal of the Division of Cancer Etiology is to understand the causes of cancer. By understanding the causes of cancer, solutions can be developed to help prevent cancer, especially in people who are at highest risk.
     
  • Division of Clinical Cancer Genetics
    The Division of Clinical Cancer Genetics includes clinical services, research, and educational programs focusing on people who are at increased risk for developing cancer because of family history or personal risk factors.
     
  • Division of Outcomes Research
    The goal of the Division of Outcomes Research is to better understand the after-effects (physical, emotional, and social) of cancer and its treatment.
    • Center for Cancer Survivorship
      This is a clinical long-term follow-up program designed to create a bridge between cancer treatment and community medical care.
       
  • Division of Nursing Research and Education
    The Division of Nursing Research and Education is well recognized on a national level for its research and education focused on nursing care for patients with cancer, which has helped to increase the quality of care provided to cancer patients across the United States.
     
  • Center of Community Alliance for Research and Education (CCARE)
    CCARE is a broad initiative that facilitates the translation of scientific knowledge into community practice to reduce and eliminate inequalities in cancer outcomes. Our mission is to increase education and awareness of the most advanced practices in health care for all patients, bringing to underrepresented and underserved patients and communities the best that City of Hope has to offer.
The Department of Radiation Biology studies the fundamental mechanisms of cancers and radiation resistance in cancer cells to find a solution to improve the efficacy of radiation therapy.

 
 

Research Department Chairs

Research Department Chairs

Research Division Directors

Research Division Directors

Milestones: 2001 - Present

Beckman Research Institute Milestones

2001
The Graduate School of Biological Sciences is accredited.

Fouad Kandeel, M.D., Ph.D., wins NIH approval for City of Hope as one of 10 national centers for isolating and distributing islet cells for transplantation into patients with Type 1 diabetes.


2005
The Division of Cancer Immunotherapeutics and Tumor Immunology is created.


2006
Arthur Riggs, Ph.D., is elected to the National Academy of Sciences in recognition of his work explaining how methylation modifies and changes the function of DNA.


2007
Groundbreaking on the Arnold and Mabel Beckman Center for Cancer Immunotherapeutics and Tumor Immunology.


2008
John Rossi, Ph.D., and John Zaia, M.D., open the first-in-human clinical trial for HIV related malignancies using a lentiviral vector to deliver a triple small RNA based gene therapy.

Richard Jove, Ph.D., is named director of the Beckman Research Institute.

Arthur Riggs, Ph.D., receives California Institute of Technology Distinguished Alumni Award.

The Department of Diabetes and Metabolic Diseases is created.
 

Milestones: 1984-2000

Beckman Research Institute Milestones

1984
The Beckman Research Institute is dedicated.

Arthur Riggs, Ph.D., and Shmuel Cabilly, Ph.D., demonstrate the feasibility and describe a method for making humanized monoclonal antibodies, technology later used in “smart” cancer drugs such as Herceptin, Rituxan and Avastin.


1988
Eugene Roberts, Ph.D., is elected to the National Academy of Sciences in recognition of his work on the existence and function of GABA and other neurotransmitters on the brain and nervous system.


1990
John Rossi, Ph.D., reports first use of RNA to block the progress of the virus that causes AIDS.


1994
The Graduate School of Biological Sciences is chartered.


1996
The Division of Molecular Medicine is created.

Gerd Pfeifer, Ph.D., definitively links smoking to lung cancer, identifying the genetic damage done by the active compounds in cigarettes.


1998
The Division of Molecular Biology is created.

Barry Forman, M.D., Ph.D., identifies the first new steroid-like hormone in 30 years, androstanol, a hormone that reverses or halts gene activity.


1999
The Division of Virology is created.

Arthur Riggs, Ph.D., is named Director of the Beckman Research Institute.


2000
The Center for Biomedicine & Genetics is established to ensure that City of Hope scientific discoveries are efficiently translated from the research lab to the clinical setting.

Milestones: 1952-1983

Beckman Research Institute Milestones

These milestones outline how Beckman Research Institute of City of Hope has grown to become one of the nation’s premier centers for innovative biomedical research, advancing the fundamental understanding of molecular genetics, cellular biology and more.
 
1952
The Research Institute is dedicated
 
1960s
The Division of Neurosciences is created.

The Division of Biology is created.


1972
The Division of Immunology is created.


1976
The Bone Marrow Transplantation Program is initiated, making City of Hope one of the first of six medical centers in the nation to perform this lifesaving procedure.

Ernest Beutler, M.D., is elected to the National Academy of Sciences in recognition of his research on the genetics of hematological diseases.


1978
Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., synthesize the human insulin gene resulting in the production of Humulin®, a pure source of human insulin available to people with diabetes.


1979
Keiichi Itakura, Ph.D., and Arthur Riggs, Ph.D., pioneer the recombinant DNA techniques used to synthesize human growth hormone, enabling thousands of undersized youngsters to reach near-normal height.


1981
The National Cancer Institute awards the first in a series of major grants to City of Hope’s Bone Marrow Transplantation Program.

Susumu Ohno, D.V.M., Ph.D., is elected to the National Academy of Sciences in recognition of his work on X chromosome inactivation and his theory of evolution by gene duplication.


1982
Yoko Fujita-Yamaguchi, Ph.D., purifies the insulin receptor molecule.


1983
The Arnold and Mabel Beckman Foundation provides a $10 million grant to establish the Beckman Research Institute of City of Hope.

Rachmiel Levine, M.D., is elected to the National Academy of Sciences in recognition of his pioneering work on discovering how insulin controls blood sugar levels.
 
Research Departments/Divisions

City of Hope is a leader in translational research - integrating basic science, clinical research and patient care.
 

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

City of Hope’s Irell & Manella Graduate School of Biological Sciences equips students with the skills and strategies to transform the future of modern medicine.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • It was 2009 when a City of Hope patient in her 40s learned that the cancer she had been fighting for several years had metastasized to her lungs. Her medical team ran genetic tests on the tumor, but none of the drug therapies available at the time targeted the known mutations in the tumor cells. […]
  • Acute myeloid leukemia (AML) is characterized by a rapidly-developing cancer in the myeloid line of blood cells, which is responsible for producing red blood cells, platelets and several types of white blood cells called granulocytes. Because AML grows rapidly, it can quickly crowd out normal blood cells, leadi...
  • Rachel Divine is a yoga therapist and patient leader for the Sheri & Les Biller Patient and Family Resource Center. She’s also a former City of Hope patient. When someone you know has cancer, even the word “cancer” can make you feel nervous, sleepless, depressed or more. But, as a yoga teacher for 15 ...
  •   Diagnosed with type 1 diabetes when she was 9 years old, Gina Marchini accepted the fact that she would need insulin the rest of her life. Every day, she injected herself with the lifesaving hormone. She also carefully controlled her diet and monitored the rise and fall of her blood glucose with military...
  • The defeat of cancer will require a team effort. Nowhere is this more necessary (or apparent) than in efforts to combat two of the most deadly forms of the disease  – pancreatic cancer and triple-negative breast cancer. It’s the approach City of Hope is taking with its newly launched multidisciplinary teams, br...
  • It’s a reasonable question: Why is the National Cancer Institute funding a study on preventing heart failure? The answer is reasonable as well: Rates of heart failure are drastically high among childhood cancer survivors — 15 times higher than among people the same age who were never treated for cancer. T...
  • Many teenagers take a break from academics during the summer, but not the eight high school students enrolled in the California Institute for Regenerative Medicine (CIRM) Creativity Awards program at City of Hope. They took the opportunity to obtain as much hands-on research experience as possible, learning fro...
  • About one in eight women will develop breast cancer at some point in her life. In fact, breast cancer is the most common cancer in American women, behind skin cancer. Although women can’t change some risk factors, such as genetics and the natural aging process, there are certain things they can do to lower thei...
  • As genetic testing becomes more sophisticated, doctors and their patients are finding that such tests can lead to the discovery of previously unknown cancer risks. In his practice at City of Hope, Thomas Slavin, M.D., an assistant clinical professor in the Division of Clinical Cancer Genetics, sees the full spe...
  • And the winners are … everyone in the San Gabriel Valley. The recipients of City of Hope’s first-ever Healthy Living grants have been announced, and the future is looking healthier already. In selecting San Gabriel Valley organizations to receive the grants, City of Hope’s Community Benefits Advisory Council ch...
  • Barry Leshowitz is a former City of Hope patient and a family advisor for the Sheri & Les Biller Patient and Family Resource Center. It’s been almost seven years since I checked into a local hospital in Phoenix for a hip replacement, only to be informed by the surgeon that he had canceled the surgery....
  • When it comes to science, the best graduate schools don’t just train scientists, they prepare their students for a lifetime of learning, accomplishment and positive impact on society. At City of Hope, the Irell & Manella Graduate School of Biological Sciences goes one step further – by preparing students to...
  • Cancer affects not just the cancer patient, but everyone around him or her, even after treatment is complete. The challenges can include the fear of cancer recurrence, coping with cancer’s economic impact and the struggle to achieve work-life balance post-treatment. Family members and loved ones of cancer patie...
  •   Bladder cancer facts: Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. 2015 estimates: 74,000 new cases of bladder cancer diagnosed 16,000 deaths from bladder cancer (about 11,510 in men and 4,490 in women) Risk factors for bladder cancer: Smoking: Smokers...
  • Women with ovarian cancer have questions about the most promising treatment options, revolutionary research avenues, survivorship and, of course, the potential impact on their personal lives. Now, together in one place, are experts who can provide answers. On Saturday, Sept. 12, the 2015 Ovarian Cancer Survivor...